Clinical trial
Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric…
NCT00224003 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00224003 |
|---|---|
| Title | Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients |
| Official title | Open-Label, Multi-Center Study of the Safety and Efficacy of Ferrlecit® in the Maintenance of Iron Stores in Pediatric Hemodialysis Patients Receiving Epoetin |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Sodium Ferric Gluconate Complex in Sucrose. |
| Enrollment | 23 |
| Start date | Apr 1, 2003 |
| Primary completion | Mar 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 28, 2009 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: